Basel Medical Group Ltd
BMGL
$0.77
-$0.09-10.37%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.55M | 7.96M | 7.48M | 7.48M | 7.46M |
| Total Other Revenue | 594.40K | 435.90K | 289.60K | 287.90K | 286.20K |
| Total Revenue | 9.14M | 8.40M | 7.77M | 7.77M | 7.74M |
| Cost of Revenue | 6.74M | 6.02M | 5.39M | 4.88M | 4.37M |
| Gross Profit | 2.40M | 2.38M | 2.39M | 2.88M | 3.37M |
| SG&A Expenses | 568.60K | 583.20K | 609.00K | 565.20K | 520.90K |
| Depreciation & Amortization | 891.90K | 670.20K | 460.80K | 427.30K | 392.30K |
| Other Operating Expenses | 1.88M | 1.54M | 1.22M | 887.90K | 547.90K |
| Total Operating Expenses | 10.08M | 8.82M | 7.68M | 6.76M | 5.83M |
| Operating Income | -935.50K | -417.40K | 94.00K | 1.00M | 1.91M |
| Income Before Tax | -9.45M | -4.59M | 107.40K | 944.40K | 1.78M |
| Income Tax Expenses | -315.40K | -258.00K | -207.40K | 19.10K | 245.60K |
| Earnings from Continuing Operations | -9.13 | -4.33 | 0.32 | 0.93 | 1.54 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 400.00 | 200.00 | -- | -- | -- |
| Net Income | -9.13M | -4.33M | 315.00K | 925.50K | 1.54M |
| EBIT | -935.50K | -417.40K | 94.00K | 1.00M | 1.91M |
| EBITDA | -854.20K | -364.40K | 120.00K | 1.03M | 1.94M |
| EPS Basic | -0.43 | -0.20 | 0.02 | 0.06 | 0.09 |
| Normalized Basic EPS | -0.03 | -0.01 | 0.00 | 0.04 | 0.07 |
| EPS Diluted | -0.43 | -0.20 | 0.02 | 0.06 | 0.09 |
| Normalized Diluted EPS | -0.03 | -0.01 | 0.00 | 0.04 | 0.07 |
| Average Basic Shares Outstanding | 75.14M | 70.07M | 65.00M | 65.00M | 65.00M |
| Average Diluted Shares Outstanding | 75.14M | 70.07M | 65.00M | 65.00M | 65.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |